| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $67.8M | +9.5% |
| R&D Expense | $137.2M | +31.4% |
| SG&A Expense | $59.5M | +6.3% |
| Operating Income | -$128.9M | -30.9% |
| Interest Expense | $2.4M | -7.7% |
| Pre-tax Income | -$116.7M | -10.6% |
| Income Tax | $2.5M | — |
| Net Income | -$119.2M | -12.9% |
| EPS (Basic) | -$2.35 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.3M | +55.4% |
| Short-term Investments | $255.1M | +95.7% |
| Accounts Receivable | $7.1M | -42.8% |
| Current Assets | $353.2M | +61.6% |
| Total Assets | $406.9M | +19.2% |
| Current Liabilities | $66.5M | +59.4% |
| Long-term Debt | $16.3M | -35.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.5M | +104.3% |
| Investing Cash Flow | -$35.0M | +64.0% |
| Financing Cash Flow | $48.3M | +1383.8% |
| -2.6% |
| EPS (Diluted) | -$2.35 | -2.6% |
| Total Liabilities |
| $189.9M |
| +113.7% |
| Stockholders' Equity | $217.0M | -14.1% |